 | • レポートコード：QY2207E09991 • 出版社/出版日：QYResearch / 2022年7月 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,102,500 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症のパンデミックにより、世界のポイントオブケア（POC）分子診断ソリューションの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にポイントオブケア（POC）分子診断ソリューションの世界市場のxxx％を占める「アッセイ＆キット」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「医院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のポイントオブケア（POC）分子診断ソリューションの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのポイントオブケア（POC）分子診断ソリューション市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのポイントオブケア（POC）分子診断ソリューション市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 ポイントオブケア（POC）分子診断ソリューションのグローバル主要メーカーには、Abbott Laboratories、F. Hoffmann-La Roche AG、Becton, Dickinson and Company、BioMerieux、Bio-Rad Laboratories, Inc.、Cepheid, Inc.、Danaher Corporation、Johnson and Johnson、Bayer Healthcareなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 ポイントオブケア（POC）分子診断ソリューション市場は、種類と用途によって区分されます。世界のポイントオブケア（POC）分子診断ソリューション市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 アッセイ＆キット、機器＆アナライザー、ソフトウェア＆サービス 【用途別セグメント】 医院、病院＆ICU、研究所、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - ポイントオブケア（POC）分子診断ソリューション製品概要 - 種類別市場（アッセイ＆キット、機器＆アナライザー、ソフトウェア＆サービス） - 用途別市場（医院、病院＆ICU、研究所、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のポイントオブケア（POC）分子診断ソリューション販売量予測2017-2028 - 世界のポイントオブケア（POC）分子診断ソリューション売上予測2017-2028 - ポイントオブケア（POC）分子診断ソリューションの地域別販売量 - ポイントオブケア（POC）分子診断ソリューションの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別ポイントオブケア（POC）分子診断ソリューション販売量 - 主要メーカー別ポイントオブケア（POC）分子診断ソリューション売上 - 主要メーカー別ポイントオブケア（POC）分子診断ソリューション価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（アッセイ＆キット、機器＆アナライザー、ソフトウェア＆サービス） - ポイントオブケア（POC）分子診断ソリューションの種類別販売量 - ポイントオブケア（POC）分子診断ソリューションの種類別売上 - ポイントオブケア（POC）分子診断ソリューションの種類別価格 ・用途別市場規模（医院、病院＆ICU、研究所、その他） - ポイントオブケア（POC）分子診断ソリューションの用途別販売量 - ポイントオブケア（POC）分子診断ソリューションの用途別売上 - ポイントオブケア（POC）分子診断ソリューションの用途別価格 ・北米市場 - 北米のポイントオブケア（POC）分子診断ソリューション市場規模（種類別、用途別） - 主要国別のポイントオブケア（POC）分子診断ソリューション市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのポイントオブケア（POC）分子診断ソリューション市場規模（種類別、用途別） - 主要国別のポイントオブケア（POC）分子診断ソリューション市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のポイントオブケア（POC）分子診断ソリューション市場規模（種類別、用途別） - 主要国別のポイントオブケア（POC）分子診断ソリューション市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のポイントオブケア（POC）分子診断ソリューション市場規模（種類別、用途別） - 主要国別のポイントオブケア（POC）分子診断ソリューション市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのポイントオブケア（POC）分子診断ソリューション市場規模（種類別、用途別） - 主要国別のポイントオブケア（POC）分子診断ソリューション市場規模（トルコ、サウジアラビア） ・企業情報 Abbott Laboratories、F. Hoffmann-La Roche AG、Becton, Dickinson and Company、BioMerieux、Bio-Rad Laboratories, Inc.、Cepheid, Inc.、Danaher Corporation、Johnson and Johnson、Bayer Healthcare ・産業チェーン及び販売チャネル分析 - ポイントオブケア（POC）分子診断ソリューションの産業チェーン分析 - ポイントオブケア（POC）分子診断ソリューションの原材料 - ポイントオブケア（POC）分子診断ソリューションの生産プロセス - ポイントオブケア（POC）分子診断ソリューションの販売及びマーケティング - ポイントオブケア（POC）分子診断ソリューションの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - ポイントオブケア（POC）分子診断ソリューションの産業動向 - ポイントオブケア（POC）分子診断ソリューションのマーケットドライバー - ポイントオブケア（POC）分子診断ソリューションの課題 - ポイントオブケア（POC）分子診断ソリューションの阻害要因 ・主な調査結果 |
Market Analysis and Insights: Global Point-of-care Molecular Diagnostic Solution Market
The global Point-of-care Molecular Diagnostic Solution market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Assays & kits accounting for % of the Point-of-care Molecular Diagnostic Solution global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Physicians’ Offices segment is altered to an % CAGR throughout this forecast period.
China Point-of-care Molecular Diagnostic Solution market size is valued at US$ million in 2021, while the North America and Europe Point-of-care Molecular Diagnostic Solution are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Point-of-care Molecular Diagnostic Solution landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Point-of-care Molecular Diagnostic Solution market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Point-of-care Molecular Diagnostic Solution market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Point-of-care Molecular Diagnostic Solution market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Point-of-care Molecular Diagnostic Solution market.
Global Point-of-care Molecular Diagnostic Solution Scope and Market Size
Point-of-care Molecular Diagnostic Solution market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Point-of-care Molecular Diagnostic Solution market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Assays & kits
Instruments & Analyzers
Software & Services
Segment by Application
Physicians’ Offices
Hospitals & ICUs
Research Institutes
Other End Users
By Company
Abbott Laboratories
F. Hoffmann-La Roche AG
Becton, Dickinson and Company
BioMerieux
Bio-Rad Laboratories, Inc.
Cepheid, Inc.
Danaher Corporation
Johnson and Johnson
Bayer Healthcare
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Point-of-care Molecular Diagnostic Solution Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Assays & kits
1.2.3 Instruments & Analyzers
1.2.4 Software & Services
1.3 Market by Application
1.3.1 Global Point-of-care Molecular Diagnostic Solution Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Physicians’ Offices
1.3.3 Hospitals & ICUs
1.3.4 Research Institutes
1.3.5 Other End Users
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Point-of-care Molecular Diagnostic Solution Market Perspective (2017-2028)
2.2 Point-of-care Molecular Diagnostic Solution Growth Trends by Region
2.2.1 Point-of-care Molecular Diagnostic Solution Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Point-of-care Molecular Diagnostic Solution Historic Market Size by Region (2017-2022)
2.2.3 Point-of-care Molecular Diagnostic Solution Forecasted Market Size by Region (2023-2028)
2.3 Point-of-care Molecular Diagnostic Solution Market Dynamics
2.3.1 Point-of-care Molecular Diagnostic Solution Industry Trends
2.3.2 Point-of-care Molecular Diagnostic Solution Market Drivers
2.3.3 Point-of-care Molecular Diagnostic Solution Market Challenges
2.3.4 Point-of-care Molecular Diagnostic Solution Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Point-of-care Molecular Diagnostic Solution Players by Revenue
3.1.1 Global Top Point-of-care Molecular Diagnostic Solution Players by Revenue (2017-2022)
3.1.2 Global Point-of-care Molecular Diagnostic Solution Revenue Market Share by Players (2017-2022)
3.2 Global Point-of-care Molecular Diagnostic Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Point-of-care Molecular Diagnostic Solution Revenue
3.4 Global Point-of-care Molecular Diagnostic Solution Market Concentration Ratio
3.4.1 Global Point-of-care Molecular Diagnostic Solution Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Point-of-care Molecular Diagnostic Solution Revenue in 2021
3.5 Point-of-care Molecular Diagnostic Solution Key Players Head office and Area Served
3.6 Key Players Point-of-care Molecular Diagnostic Solution Product Solution and Service
3.7 Date of Enter into Point-of-care Molecular Diagnostic Solution Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Point-of-care Molecular Diagnostic Solution Breakdown Data by Type
4.1 Global Point-of-care Molecular Diagnostic Solution Historic Market Size by Type (2017-2022)
4.2 Global Point-of-care Molecular Diagnostic Solution Forecasted Market Size by Type (2023-2028)
5 Point-of-care Molecular Diagnostic Solution Breakdown Data by Application
5.1 Global Point-of-care Molecular Diagnostic Solution Historic Market Size by Application (2017-2022)
5.2 Global Point-of-care Molecular Diagnostic Solution Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Point-of-care Molecular Diagnostic Solution Market Size (2017-2028)
6.2 North America Point-of-care Molecular Diagnostic Solution Market Size by Type
6.2.1 North America Point-of-care Molecular Diagnostic Solution Market Size by Type (2017-2022)
6.2.2 North America Point-of-care Molecular Diagnostic Solution Market Size by Type (2023-2028)
6.2.3 North America Point-of-care Molecular Diagnostic Solution Market Share by Type (2017-2028)
6.3 North America Point-of-care Molecular Diagnostic Solution Market Size by Application
6.3.1 North America Point-of-care Molecular Diagnostic Solution Market Size by Application (2017-2022)
6.3.2 North America Point-of-care Molecular Diagnostic Solution Market Size by Application (2023-2028)
6.3.3 North America Point-of-care Molecular Diagnostic Solution Market Share by Application (2017-2028)
6.4 North America Point-of-care Molecular Diagnostic Solution Market Size by Country
6.4.1 North America Point-of-care Molecular Diagnostic Solution Market Size by Country (2017-2022)
6.4.2 North America Point-of-care Molecular Diagnostic Solution Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Point-of-care Molecular Diagnostic Solution Market Size (2017-2028)
7.2 Europe Point-of-care Molecular Diagnostic Solution Market Size by Type
7.2.1 Europe Point-of-care Molecular Diagnostic Solution Market Size by Type (2017-2022)
7.2.2 Europe Point-of-care Molecular Diagnostic Solution Market Size by Type (2023-2028)
7.2.3 Europe Point-of-care Molecular Diagnostic Solution Market Share by Type (2017-2028)
7.3 Europe Point-of-care Molecular Diagnostic Solution Market Size by Application
7.3.1 Europe Point-of-care Molecular Diagnostic Solution Market Size by Application (2017-2022)
7.3.2 Europe Point-of-care Molecular Diagnostic Solution Market Size by Application (2023-2028)
7.3.3 Europe Point-of-care Molecular Diagnostic Solution Market Share by Application (2017-2028)
7.4 Europe Point-of-care Molecular Diagnostic Solution Market Size by Country
7.4.1 Europe Point-of-care Molecular Diagnostic Solution Market Size by Country (2017-2022)
7.4.2 Europe Point-of-care Molecular Diagnostic Solution Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Size (2017-2028)
8.2 Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Size by Type
8.2.1 Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Share by Type (2017-2028)
8.3 Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Size by Application
8.3.1 Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Share by Application (2017-2028)
8.4 Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Size by Region
8.4.1 Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Point-of-care Molecular Diagnostic Solution Market Size (2017-2028)
9.2 Latin America Point-of-care Molecular Diagnostic Solution Market Size by Type
9.2.1 Latin America Point-of-care Molecular Diagnostic Solution Market Size by Type (2017-2022)
9.2.2 Latin America Point-of-care Molecular Diagnostic Solution Market Size by Type (2023-2028)
9.2.3 Latin America Point-of-care Molecular Diagnostic Solution Market Share by Type (2017-2028)
9.3 Latin America Point-of-care Molecular Diagnostic Solution Market Size by Application
9.3.1 Latin America Point-of-care Molecular Diagnostic Solution Market Size by Application (2017-2022)
9.3.2 Latin America Point-of-care Molecular Diagnostic Solution Market Size by Application (2023-2028)
9.3.3 Latin America Point-of-care Molecular Diagnostic Solution Market Share by Application (2017-2028)
9.4 Latin America Point-of-care Molecular Diagnostic Solution Market Size by Country
9.4.1 Latin America Point-of-care Molecular Diagnostic Solution Market Size by Country (2017-2022)
9.4.2 Latin America Point-of-care Molecular Diagnostic Solution Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Point-of-care Molecular Diagnostic Solution Market Size (2017-2028)
10.2 Middle East & Africa Point-of-care Molecular Diagnostic Solution Market Size by Type
10.2.1 Middle East & Africa Point-of-care Molecular Diagnostic Solution Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Point-of-care Molecular Diagnostic Solution Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Point-of-care Molecular Diagnostic Solution Market Share by Type (2017-2028)
10.3 Middle East & Africa Point-of-care Molecular Diagnostic Solution Market Size by Application
10.3.1 Middle East & Africa Point-of-care Molecular Diagnostic Solution Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Point-of-care Molecular Diagnostic Solution Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Point-of-care Molecular Diagnostic Solution Market Share by Application (2017-2028)
10.4 Middle East & Africa Point-of-care Molecular Diagnostic Solution Market Size by Country
10.4.1 Middle East & Africa Point-of-care Molecular Diagnostic Solution Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Point-of-care Molecular Diagnostic Solution Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Point-of-care Molecular Diagnostic Solution Introduction
11.1.4 Abbott Laboratories Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
11.1.5 Abbott Laboratories Recent Developments
11.2 F. Hoffmann-La Roche AG
11.2.1 F. Hoffmann-La Roche AG Company Details
11.2.2 F. Hoffmann-La Roche AG Business Overview
11.2.3 F. Hoffmann-La Roche AG Point-of-care Molecular Diagnostic Solution Introduction
11.2.4 F. Hoffmann-La Roche AG Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
11.2.5 F. Hoffmann-La Roche AG Recent Developments
11.3 Becton, Dickinson and Company
11.3.1 Becton, Dickinson and Company Company Details
11.3.2 Becton, Dickinson and Company Business Overview
11.3.3 Becton, Dickinson and Company Point-of-care Molecular Diagnostic Solution Introduction
11.3.4 Becton, Dickinson and Company Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
11.3.5 Becton, Dickinson and Company Recent Developments
11.4 BioMerieux
11.4.1 BioMerieux Company Details
11.4.2 BioMerieux Business Overview
11.4.3 BioMerieux Point-of-care Molecular Diagnostic Solution Introduction
11.4.4 BioMerieux Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
11.4.5 BioMerieux Recent Developments
11.5 Bio-Rad Laboratories, Inc.
11.5.1 Bio-Rad Laboratories, Inc. Company Details
11.5.2 Bio-Rad Laboratories, Inc. Business Overview
11.5.3 Bio-Rad Laboratories, Inc. Point-of-care Molecular Diagnostic Solution Introduction
11.5.4 Bio-Rad Laboratories, Inc. Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
11.5.5 Bio-Rad Laboratories, Inc. Recent Developments
11.6 Cepheid, Inc.
11.6.1 Cepheid, Inc. Company Details
11.6.2 Cepheid, Inc. Business Overview
11.6.3 Cepheid, Inc. Point-of-care Molecular Diagnostic Solution Introduction
11.6.4 Cepheid, Inc. Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
11.6.5 Cepheid, Inc. Recent Developments
11.7 Danaher Corporation
11.7.1 Danaher Corporation Company Details
11.7.2 Danaher Corporation Business Overview
11.7.3 Danaher Corporation Point-of-care Molecular Diagnostic Solution Introduction
11.7.4 Danaher Corporation Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
11.7.5 Danaher Corporation Recent Developments
11.8 Johnson and Johnson
11.8.1 Johnson and Johnson Company Details
11.8.2 Johnson and Johnson Business Overview
11.8.3 Johnson and Johnson Point-of-care Molecular Diagnostic Solution Introduction
11.8.4 Johnson and Johnson Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
11.8.5 Johnson and Johnson Recent Developments
11.9 Bayer Healthcare
11.9.1 Bayer Healthcare Company Details
11.9.2 Bayer Healthcare Business Overview
11.9.3 Bayer Healthcare Point-of-care Molecular Diagnostic Solution Introduction
11.9.4 Bayer Healthcare Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
11.9.5 Bayer Healthcare Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
Table 1. Global Point-of-care Molecular Diagnostic Solution Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Assays & kits
Table 3. Key Players of Instruments & Analyzers
Table 4. Key Players of Software & Services
Table 5. Global Point-of-care Molecular Diagnostic Solution Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Point-of-care Molecular Diagnostic Solution Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Point-of-care Molecular Diagnostic Solution Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Point-of-care Molecular Diagnostic Solution Market Share by Region (2017-2022)
Table 9. Global Point-of-care Molecular Diagnostic Solution Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Point-of-care Molecular Diagnostic Solution Market Share by Region (2023-2028)
Table 11. Point-of-care Molecular Diagnostic Solution Market Trends
Table 12. Point-of-care Molecular Diagnostic Solution Market Drivers
Table 13. Point-of-care Molecular Diagnostic Solution Market Challenges
Table 14. Point-of-care Molecular Diagnostic Solution Market Restraints
Table 15. Global Point-of-care Molecular Diagnostic Solution Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Point-of-care Molecular Diagnostic Solution Revenue Share by Players (2017-2022)
Table 17. Global Top Point-of-care Molecular Diagnostic Solution by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point-of-care Molecular Diagnostic Solution as of 2021)
Table 18. Ranking of Global Top Point-of-care Molecular Diagnostic Solution Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Point-of-care Molecular Diagnostic Solution Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Point-of-care Molecular Diagnostic Solution Product Solution and Service
Table 22. Date of Enter into Point-of-care Molecular Diagnostic Solution Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Point-of-care Molecular Diagnostic Solution Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Point-of-care Molecular Diagnostic Solution Revenue Market Share by Type (2017-2022)
Table 26. Global Point-of-care Molecular Diagnostic Solution Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Point-of-care Molecular Diagnostic Solution Revenue Market Share by Type (2023-2028)
Table 28. Global Point-of-care Molecular Diagnostic Solution Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Point-of-care Molecular Diagnostic Solution Revenue Share by Application (2017-2022)
Table 30. Global Point-of-care Molecular Diagnostic Solution Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Point-of-care Molecular Diagnostic Solution Revenue Share by Application (2023-2028)
Table 32. North America Point-of-care Molecular Diagnostic Solution Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Point-of-care Molecular Diagnostic Solution Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Point-of-care Molecular Diagnostic Solution Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Point-of-care Molecular Diagnostic Solution Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Point-of-care Molecular Diagnostic Solution Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Point-of-care Molecular Diagnostic Solution Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Point-of-care Molecular Diagnostic Solution Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Point-of-care Molecular Diagnostic Solution Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Point-of-care Molecular Diagnostic Solution Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Point-of-care Molecular Diagnostic Solution Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Point-of-care Molecular Diagnostic Solution Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Point-of-care Molecular Diagnostic Solution Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Point-of-care Molecular Diagnostic Solution Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Point-of-care Molecular Diagnostic Solution Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Point-of-care Molecular Diagnostic Solution Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Point-of-care Molecular Diagnostic Solution Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Point-of-care Molecular Diagnostic Solution Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Point-of-care Molecular Diagnostic Solution Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Point-of-care Molecular Diagnostic Solution Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Point-of-care Molecular Diagnostic Solution Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Point-of-care Molecular Diagnostic Solution Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Point-of-care Molecular Diagnostic Solution Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Point-of-care Molecular Diagnostic Solution Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Point-of-care Molecular Diagnostic Solution Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Point-of-care Molecular Diagnostic Solution Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Point-of-care Molecular Diagnostic Solution Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Point-of-care Molecular Diagnostic Solution Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Point-of-care Molecular Diagnostic Solution Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Point-of-care Molecular Diagnostic Solution Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Point-of-care Molecular Diagnostic Solution Market Size by Country (2023-2028) & (US$ Million)
Table 62. Abbott Laboratories Company Details
Table 63. Abbott Laboratories Business Overview
Table 64. Abbott Laboratories Point-of-care Molecular Diagnostic Solution Product
Table 65. Abbott Laboratories Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022) & (US$ Million)
Table 66. Abbott Laboratories Recent Developments
Table 67. F. Hoffmann-La Roche AG Company Details
Table 68. F. Hoffmann-La Roche AG Business Overview
Table 69. F. Hoffmann-La Roche AG Point-of-care Molecular Diagnostic Solution Product
Table 70. F. Hoffmann-La Roche AG Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022) & (US$ Million)
Table 71. F. Hoffmann-La Roche AG Recent Developments
Table 72. Becton, Dickinson and Company Company Details
Table 73. Becton, Dickinson and Company Business Overview
Table 74. Becton, Dickinson and Company Point-of-care Molecular Diagnostic Solution Product
Table 75. Becton, Dickinson and Company Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022) & (US$ Million)
Table 76. Becton, Dickinson and Company Recent Developments
Table 77. BioMerieux Company Details
Table 78. BioMerieux Business Overview
Table 79. BioMerieux Point-of-care Molecular Diagnostic Solution Product
Table 80. BioMerieux Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022) & (US$ Million)
Table 81. BioMerieux Recent Developments
Table 82. Bio-Rad Laboratories, Inc. Company Details
Table 83. Bio-Rad Laboratories, Inc. Business Overview
Table 84. Bio-Rad Laboratories, Inc. Point-of-care Molecular Diagnostic Solution Product
Table 85. Bio-Rad Laboratories, Inc. Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022) & (US$ Million)
Table 86. Bio-Rad Laboratories, Inc. Recent Developments
Table 87. Cepheid, Inc. Company Details
Table 88. Cepheid, Inc. Business Overview
Table 89. Cepheid, Inc. Point-of-care Molecular Diagnostic Solution Product
Table 90. Cepheid, Inc. Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022) & (US$ Million)
Table 91. Cepheid, Inc. Recent Developments
Table 92. Danaher Corporation Company Details
Table 93. Danaher Corporation Business Overview
Table 94. Danaher Corporation Point-of-care Molecular Diagnostic Solution Product
Table 95. Danaher Corporation Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022) & (US$ Million)
Table 96. Danaher Corporation Recent Developments
Table 97. Johnson and Johnson Company Details
Table 98. Johnson and Johnson Business Overview
Table 99. Johnson and Johnson Point-of-care Molecular Diagnostic Solution Product
Table 100. Johnson and Johnson Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022) & (US$ Million)
Table 101. Johnson and Johnson Recent Developments
Table 102. Bayer Healthcare Company Details
Table 103. Bayer Healthcare Business Overview
Table 104. Bayer Healthcare Point-of-care Molecular Diagnostic Solution Product
Table 105. Bayer Healthcare Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022) & (US$ Million)
Table 106. Bayer Healthcare Recent Developments
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Point-of-care Molecular Diagnostic Solution Market Share by Type: 2021 VS 2028
Figure 2. Assays & kits Features
Figure 3. Instruments & Analyzers Features
Figure 4. Software & Services Features
Figure 5. Global Point-of-care Molecular Diagnostic Solution Market Share by Application: 2021 VS 2028
Figure 6. Physicians’ Offices Case Studies
Figure 7. Hospitals & ICUs Case Studies
Figure 8. Research Institutes Case Studies
Figure 9. Other End Users Case Studies
Figure 10. Point-of-care Molecular Diagnostic Solution Report Years Considered
Figure 11. Global Point-of-care Molecular Diagnostic Solution Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Point-of-care Molecular Diagnostic Solution Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Point-of-care Molecular Diagnostic Solution Market Share by Region: 2021 VS 2028
Figure 14. Global Point-of-care Molecular Diagnostic Solution Market Share by Players in 2021
Figure 15. Global Top Point-of-care Molecular Diagnostic Solution Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point-of-care Molecular Diagnostic Solution as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Point-of-care Molecular Diagnostic Solution Revenue in 2021
Figure 17. North America Point-of-care Molecular Diagnostic Solution Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Point-of-care Molecular Diagnostic Solution Market Size Market Share by Type (2017-2028)
Figure 19. North America Point-of-care Molecular Diagnostic Solution Market Size Market Share by Application (2017-2028)
Figure 20. North America Point-of-care Molecular Diagnostic Solution Market Size Share by Country (2017-2028)
Figure 21. United States Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Point-of-care Molecular Diagnostic Solution Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Point-of-care Molecular Diagnostic Solution Market Size Market Share by Type (2017-2028)
Figure 25. Europe Point-of-care Molecular Diagnostic Solution Market Size Market Share by Application (2017-2028)
Figure 26. Europe Point-of-care Molecular Diagnostic Solution Market Size Share by Country (2017-2028)
Figure 27. Germany Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Point-of-care Molecular Diagnostic Solution Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Point-of-care Molecular Diagnostic Solution Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Point-of-care Molecular Diagnostic Solution Market Size Share by Region (2017-2028)
Figure 37. China Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 43. Latin America Point-of-care Molecular Diagnostic Solution Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Point-of-care Molecular Diagnostic Solution Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Point-of-care Molecular Diagnostic Solution Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Point-of-care Molecular Diagnostic Solution Market Size Share by Country (2017-2028)
Figure 47. Mexico Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Point-of-care Molecular Diagnostic Solution Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Point-of-care Molecular Diagnostic Solution Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Point-of-care Molecular Diagnostic Solution Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Point-of-care Molecular Diagnostic Solution Market Size Share by Country (2017-2028)
Figure 53. Turkey Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Abbott Laboratories Revenue Growth Rate in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
Figure 57. F. Hoffmann-La Roche AG Revenue Growth Rate in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
Figure 58. Becton, Dickinson and Company Revenue Growth Rate in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
Figure 59. BioMerieux Revenue Growth Rate in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
Figure 60. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
Figure 61. Cepheid, Inc. Revenue Growth Rate in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
Figure 62. Danaher Corporation Revenue Growth Rate in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
Figure 63. Johnson and Johnson Revenue Growth Rate in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
Figure 64. Bayer Healthcare Revenue Growth Rate in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
ポイントオブケア（POC）アナライザーのグローバル市場インサイト・予測（～2028年） Point of care testing has reduced critical time on waiting for test results from the lab. Point-of-care (POC) analyzers refer to the medical diagnostic devices that are specifically designed for use within doctors' surgeries, hopsitals, laboratories and clinics to provide fast and accurate results a…- 世界のポイントオブケア（POC）装置市場予測（～2028年）：血糖診断用、感染症診断用、妊娠診断用、尿検査診断用、その他 The Point of Care (POC) Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade reg…
- 世界の獣医用ポイントオブケア（POC）診断市場予測（～2028年）：イメージングシステム、アナライザー、試薬 The Veterinary Point-of-Care (POC) Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiza…
- 分子診断感染症検査のグローバル市場インサイト・予測（～2028年） Molecular diagnostics is a technique used to detect the presence of and identify genetic materials and proteins associated with specific health conditions and diseases, and infectious agents in body fluids such as blood, urine, or sputum. Molecular diagnostics for infectious disease testing is used …
- 世界のポイントオブケア超音波市場予測（～2028年）：トロリーベース、手持ち型 The Point of Care Ultrasound market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…